nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Skin necrosis—Melphalan—peripheral nervous system neoplasm	0.0222	0.0304	CcSEcCtD
Terlipressin—AVPR2—Arf6 trafficking events—NME1—peripheral nervous system neoplasm	0.0199	0.0734	CbGpPWpGaD
Terlipressin—Skin necrosis—Cisplatin—peripheral nervous system neoplasm	0.0145	0.0199	CcSEcCtD
Terlipressin—Pregnancy—Tretinoin—peripheral nervous system neoplasm	0.0138	0.019	CcSEcCtD
Terlipressin—Pregnancy—Isotretinoin—peripheral nervous system neoplasm	0.0138	0.019	CcSEcCtD
Terlipressin—Skin necrosis—Etoposide—peripheral nervous system neoplasm	0.0133	0.0182	CcSEcCtD
Terlipressin—Fluid overload—Tretinoin—peripheral nervous system neoplasm	0.0126	0.0173	CcSEcCtD
Terlipressin—Fluid overload—Isotretinoin—peripheral nervous system neoplasm	0.0126	0.0173	CcSEcCtD
Terlipressin—Respiratory distress—Tretinoin—peripheral nervous system neoplasm	0.0123	0.0169	CcSEcCtD
Terlipressin—Respiratory distress—Isotretinoin—peripheral nervous system neoplasm	0.0123	0.0169	CcSEcCtD
Terlipressin—Respiratory distress—Melphalan—peripheral nervous system neoplasm	0.0122	0.0167	CcSEcCtD
Terlipressin—Cyanosis—Tretinoin—peripheral nervous system neoplasm	0.0111	0.0152	CcSEcCtD
Terlipressin—Cyanosis—Isotretinoin—peripheral nervous system neoplasm	0.0111	0.0152	CcSEcCtD
Terlipressin—Pregnancy—Alitretinoin—peripheral nervous system neoplasm	0.0105	0.0144	CcSEcCtD
Terlipressin—AVPR1B—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00998	0.0369	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00985	0.0364	CbGpPWpGaD
Terlipressin—Fluid overload—Alitretinoin—peripheral nervous system neoplasm	0.00956	0.0131	CcSEcCtD
Terlipressin—Pallor—Tretinoin—peripheral nervous system neoplasm	0.00946	0.013	CcSEcCtD
Terlipressin—Pallor—Isotretinoin—peripheral nervous system neoplasm	0.00946	0.013	CcSEcCtD
Terlipressin—Respiratory distress—Alitretinoin—peripheral nervous system neoplasm	0.00936	0.0128	CcSEcCtD
Terlipressin—Respiratory distress—Vincristine—peripheral nervous system neoplasm	0.00902	0.0124	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00892	0.033	CbGpPWpGaD
Terlipressin—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—GNAS—peripheral nervous system neoplasm	0.00874	0.0323	CbGpPWpGaD
Terlipressin—Abdominal cramps—Vincristine—peripheral nervous system neoplasm	0.00849	0.0116	CcSEcCtD
Terlipressin—Cyanosis—Alitretinoin—peripheral nervous system neoplasm	0.0084	0.0115	CcSEcCtD
Terlipressin—Fluid overload—Cisplatin—peripheral nervous system neoplasm	0.00815	0.0112	CcSEcCtD
Terlipressin—Respiratory failure—Topotecan—peripheral nervous system neoplasm	0.00805	0.011	CcSEcCtD
Terlipressin—Respiratory failure—Tretinoin—peripheral nervous system neoplasm	0.00799	0.011	CcSEcCtD
Terlipressin—Respiratory failure—Isotretinoin—peripheral nervous system neoplasm	0.00799	0.011	CcSEcCtD
Terlipressin—AVPR2—Aquaporin-mediated transport—GNAS—peripheral nervous system neoplasm	0.00763	0.0282	CbGpPWpGaD
Terlipressin—Skin exfoliation—Tretinoin—peripheral nervous system neoplasm	0.00749	0.0103	CcSEcCtD
Terlipressin—Skin exfoliation—Isotretinoin—peripheral nervous system neoplasm	0.00749	0.0103	CcSEcCtD
Terlipressin—Skin necrosis—Epirubicin—peripheral nervous system neoplasm	0.00744	0.0102	CcSEcCtD
Terlipressin—Skin exfoliation—Melphalan—peripheral nervous system neoplasm	0.00739	0.0101	CcSEcCtD
Terlipressin—AVPR2—G alpha (s) signalling events—VIP—peripheral nervous system neoplasm	0.00723	0.0267	CbGpPWpGaD
Terlipressin—Pallor—Alitretinoin—peripheral nervous system neoplasm	0.00717	0.00983	CcSEcCtD
Terlipressin—Pulmonary oedema—Isotretinoin—peripheral nervous system neoplasm	0.00698	0.00957	CcSEcCtD
Terlipressin—Pulmonary oedema—Tretinoin—peripheral nervous system neoplasm	0.00698	0.00957	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	0.00692	0.0255	CbGpPWpGaD
Terlipressin—Skin necrosis—Doxorubicin—peripheral nervous system neoplasm	0.00689	0.00945	CcSEcCtD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00683	0.0252	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—NTS—peripheral nervous system neoplasm	0.00678	0.025	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00661	0.0244	CbGpPWpGaD
Terlipressin—Cyanosis—Etoposide—peripheral nervous system neoplasm	0.00656	0.00899	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	0.00618	0.0228	CbGpPWpGaD
Terlipressin—Respiratory failure—Alitretinoin—peripheral nervous system neoplasm	0.00605	0.0083	CcSEcCtD
Terlipressin—Atrial fibrillation—Melphalan—peripheral nervous system neoplasm	0.00593	0.00813	CcSEcCtD
Terlipressin—Cardiac failure—Isotretinoin—peripheral nervous system neoplasm	0.00583	0.008	CcSEcCtD
Terlipressin—Cardiac failure—Tretinoin—peripheral nervous system neoplasm	0.00583	0.008	CcSEcCtD
Terlipressin—Respiratory failure—Vincristine—peripheral nervous system neoplasm	0.00583	0.008	CcSEcCtD
Terlipressin—Skin exfoliation—Alitretinoin—peripheral nervous system neoplasm	0.00568	0.00778	CcSEcCtD
Terlipressin—Hyponatraemia—Melphalan—peripheral nervous system neoplasm	0.00564	0.00774	CcSEcCtD
Terlipressin—Pulmonary oedema—Alitretinoin—peripheral nervous system neoplasm	0.00529	0.00726	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00503	0.0186	CbGpPWpGaD
Terlipressin—Skin exfoliation—Cisplatin—peripheral nervous system neoplasm	0.00484	0.00663	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00482	0.0178	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00458	0.0169	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.00455	0.0168	CbGpPWpGaD
Terlipressin—AVPR1B—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00448	0.0166	CbGpPWpGaD
Terlipressin—Skin exfoliation—Etoposide—peripheral nervous system neoplasm	0.00443	0.00607	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00443	0.0164	CbGpPWpGaD
Terlipressin—Cardiac failure—Alitretinoin—peripheral nervous system neoplasm	0.00442	0.00606	CcSEcCtD
Terlipressin—Acute coronary syndrome—Isotretinoin—peripheral nervous system neoplasm	0.00433	0.00593	CcSEcCtD
Terlipressin—Acute coronary syndrome—Tretinoin—peripheral nervous system neoplasm	0.00433	0.00593	CcSEcCtD
Terlipressin—Myocardial infarction—Isotretinoin—peripheral nervous system neoplasm	0.0043	0.0059	CcSEcCtD
Terlipressin—Myocardial infarction—Tretinoin—peripheral nervous system neoplasm	0.0043	0.0059	CcSEcCtD
Terlipressin—Hyponatraemia—Vincristine—peripheral nervous system neoplasm	0.00418	0.00572	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00401	0.0148	CbGpPWpGaD
Terlipressin—AVPR2—G alpha (s) signalling events—GNAS—peripheral nervous system neoplasm	0.00375	0.0138	CbGpPWpGaD
Terlipressin—Hyponatraemia—Cisplatin—peripheral nervous system neoplasm	0.00369	0.00506	CcSEcCtD
Terlipressin—Angiopathy—Topotecan—peripheral nervous system neoplasm	0.0036	0.00494	CcSEcCtD
Terlipressin—Angiopathy—Tretinoin—peripheral nervous system neoplasm	0.00357	0.0049	CcSEcCtD
Terlipressin—Angiopathy—Isotretinoin—peripheral nervous system neoplasm	0.00357	0.0049	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00349	0.0129	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00346	0.0128	CbGpPWpGaD
Terlipressin—Malnutrition—Topotecan—peripheral nervous system neoplasm	0.00346	0.00474	CcSEcCtD
Terlipressin—Cardiac failure—Etoposide—peripheral nervous system neoplasm	0.00345	0.00473	CcSEcCtD
Terlipressin—Malnutrition—Isotretinoin—peripheral nervous system neoplasm	0.00343	0.0047	CcSEcCtD
Terlipressin—Malnutrition—Tretinoin—peripheral nervous system neoplasm	0.00343	0.0047	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00334	0.0124	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.00332	0.0123	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Alitretinoin—peripheral nervous system neoplasm	0.00328	0.0045	CcSEcCtD
Terlipressin—Myocardial infarction—Alitretinoin—peripheral nervous system neoplasm	0.00326	0.00447	CcSEcCtD
Terlipressin—Acute coronary syndrome—Vincristine—peripheral nervous system neoplasm	0.00316	0.00433	CcSEcCtD
Terlipressin—Myocardial infarction—Vincristine—peripheral nervous system neoplasm	0.00314	0.00431	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	0.00311	0.0115	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00307	0.0113	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00305	0.0113	CbGpPWpGaD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00297	0.011	CbGpPWpGaD
Terlipressin—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00296	0.00406	CcSEcCtD
Terlipressin—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00296	0.00406	CcSEcCtD
Terlipressin—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00294	0.00404	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00292	0.00401	CcSEcCtD
Terlipressin—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00292	0.004	CcSEcCtD
Terlipressin—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00292	0.004	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.0029	0.00398	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.0029	0.00398	CcSEcCtD
Terlipressin—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00288	0.00395	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Epirubicin—peripheral nervous system neoplasm	0.00288	0.00395	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00286	0.00392	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00284	0.0105	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Cisplatin—peripheral nervous system neoplasm	0.00279	0.00383	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	0.00278	0.0103	CbGpPWpGaD
Terlipressin—Myocardial infarction—Cisplatin—peripheral nervous system neoplasm	0.00278	0.00381	CcSEcCtD
Terlipressin—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00277	0.00379	CcSEcCtD
Terlipressin—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.00274	0.00376	CcSEcCtD
Terlipressin—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.00274	0.00376	CcSEcCtD
Terlipressin—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00274	0.00376	CcSEcCtD
Terlipressin—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00273	0.00375	CcSEcCtD
Terlipressin—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00273	0.00375	CcSEcCtD
Terlipressin—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00272	0.00373	CcSEcCtD
Terlipressin—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00272	0.00373	CcSEcCtD
Terlipressin—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.00271	0.00371	CcSEcCtD
Terlipressin—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.0027	0.0037	CcSEcCtD
Terlipressin—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00268	0.00368	CcSEcCtD
Terlipressin—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.00267	0.00366	CcSEcCtD
Terlipressin—Ventricular extrasystoles—Doxorubicin—peripheral nervous system neoplasm	0.00266	0.00365	CcSEcCtD
Terlipressin—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.00261	0.00358	CcSEcCtD
Terlipressin—Malnutrition—Alitretinoin—peripheral nervous system neoplasm	0.0026	0.00356	CcSEcCtD
Terlipressin—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00259	0.00355	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00258	0.00954	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.00256	0.00351	CcSEcCtD
Terlipressin—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.00254	0.00349	CcSEcCtD
Terlipressin—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00252	0.00345	CcSEcCtD
Terlipressin—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.0025	0.00342	CcSEcCtD
Terlipressin—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.0025	0.00342	CcSEcCtD
Terlipressin—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.00248	0.00341	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00248	0.00914	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00247	0.00914	CbGpPWpGaD
Terlipressin—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00246	0.00338	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.00244	0.009	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00244	0.00334	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00242	0.00331	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00242	0.00331	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00238	0.00327	CcSEcCtD
Terlipressin—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.00236	0.00324	CcSEcCtD
Terlipressin—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.00232	0.00317	CcSEcCtD
Terlipressin—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.0023	0.00315	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00226	0.00835	CbGpPWpGaD
Terlipressin—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00224	0.00308	CcSEcCtD
Terlipressin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00223	0.00306	CcSEcCtD
Terlipressin—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00221	0.00304	CcSEcCtD
Terlipressin—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00221	0.00303	CcSEcCtD
Terlipressin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00221	0.00303	CcSEcCtD
Terlipressin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00221	0.00303	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.0022	0.00301	CcSEcCtD
Terlipressin—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.00216	0.00297	CcSEcCtD
Terlipressin—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00216	0.00296	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00215	0.00796	CbGpPWpGaD
Terlipressin—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.00214	0.00294	CcSEcCtD
Terlipressin—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00211	0.0029	CcSEcCtD
Terlipressin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00208	0.00285	CcSEcCtD
Terlipressin—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00207	0.00284	CcSEcCtD
Terlipressin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00206	0.00282	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00206	0.0076	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00204	0.00755	CbGpPWpGaD
Terlipressin—Hot flush—Epirubicin—peripheral nervous system neoplasm	0.00202	0.00277	CcSEcCtD
Terlipressin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.002	0.00275	CcSEcCtD
Terlipressin—Menopausal symptoms—Epirubicin—peripheral nervous system neoplasm	0.002	0.00274	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00198	0.0073	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00197	0.00728	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00196	0.00723	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00196	0.00723	CbGpPWpGaD
Terlipressin—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.00193	0.00265	CcSEcCtD
Terlipressin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00193	0.00265	CcSEcCtD
Terlipressin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00191	0.00263	CcSEcCtD
Terlipressin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00191	0.00263	CcSEcCtD
Terlipressin—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.0019	0.0026	CcSEcCtD
Terlipressin—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00189	0.00259	CcSEcCtD
Terlipressin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00189	0.00259	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00187	0.00257	CcSEcCtD
Terlipressin—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.00187	0.00256	CcSEcCtD
Terlipressin—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.00185	0.00254	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00183	0.00251	CcSEcCtD
Terlipressin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00181	0.00248	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00181	0.00667	CbGpPWpGaD
Terlipressin—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00179	0.00246	CcSEcCtD
Terlipressin—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.00179	0.00245	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00179	0.00661	CbGpPWpGaD
Terlipressin—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00178	0.00244	CcSEcCtD
Terlipressin—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00178	0.00244	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.00178	0.00656	CbGpPWpGaD
Terlipressin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00177	0.00243	CcSEcCtD
Terlipressin—Headache—Topotecan—peripheral nervous system neoplasm	0.00177	0.00242	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00176	0.00242	CcSEcCtD
Terlipressin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00176	0.00242	CcSEcCtD
Terlipressin—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00176	0.00241	CcSEcCtD
Terlipressin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00176	0.00241	CcSEcCtD
Terlipressin—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.00241	CcSEcCtD
Terlipressin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00175	0.0024	CcSEcCtD
Terlipressin—Headache—Tretinoin—peripheral nervous system neoplasm	0.00175	0.0024	CcSEcCtD
Terlipressin—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00175	0.0024	CcSEcCtD
Terlipressin—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00173	0.00237	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00172	0.00634	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00172	0.00235	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.0017	0.00629	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.00169	0.00624	CbGpPWpGaD
Terlipressin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00168	0.0023	CcSEcCtD
Terlipressin—Nausea—Topotecan—peripheral nervous system neoplasm	0.00168	0.0023	CcSEcCtD
Terlipressin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00166	0.00228	CcSEcCtD
Terlipressin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00166	0.00228	CcSEcCtD
Terlipressin—Nausea—Melphalan—peripheral nervous system neoplasm	0.00164	0.00225	CcSEcCtD
Terlipressin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00162	0.00222	CcSEcCtD
Terlipressin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00162	0.00222	CcSEcCtD
Terlipressin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00161	0.00221	CcSEcCtD
Terlipressin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00161	0.00221	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00157	0.00579	CbGpPWpGaD
Terlipressin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00157	0.00215	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00214	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00156	0.00575	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00153	0.00563	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00149	0.00552	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00148	0.00548	CbGpPWpGaD
Terlipressin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.00148	0.00202	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.00146	0.00541	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00146	0.0054	CbGpPWpGaD
Terlipressin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00145	0.00199	CcSEcCtD
Terlipressin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00145	0.00199	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.00143	0.00196	CcSEcCtD
Terlipressin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.0014	0.00192	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00137	0.00506	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00136	0.00503	CbGpPWpGaD
Terlipressin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.00186	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00136	0.00501	CbGpPWpGaD
Terlipressin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00135	0.00185	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.00135	0.00497	CbGpPWpGaD
Terlipressin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00182	CcSEcCtD
Terlipressin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.00182	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00131	0.00484	CbGpPWpGaD
Terlipressin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00131	0.00179	CcSEcCtD
Terlipressin—Vomiting—Vincristine—peripheral nervous system neoplasm	0.0013	0.00178	CcSEcCtD
Terlipressin—Headache—Vincristine—peripheral nervous system neoplasm	0.00128	0.00176	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00128	0.00472	CbGpPWpGaD
Terlipressin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00173	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00125	0.00462	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00124	0.00459	CbGpPWpGaD
Terlipressin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00124	0.0017	CcSEcCtD
Terlipressin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00169	CcSEcCtD
Terlipressin—Nausea—Vincristine—peripheral nervous system neoplasm	0.00121	0.00166	CcSEcCtD
Terlipressin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00121	0.00166	CcSEcCtD
Terlipressin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00163	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00116	0.00429	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00116	0.00427	CbGpPWpGaD
Terlipressin—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00115	0.00158	CcSEcCtD
Terlipressin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00114	0.00156	CcSEcCtD
Terlipressin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00113	0.00155	CcSEcCtD
Terlipressin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.00112	0.00154	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.00112	0.00413	CbGpPWpGaD
Terlipressin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.0015	CcSEcCtD
Terlipressin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00147	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.00107	0.00396	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.00107	0.00394	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00106	0.00391	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00105	0.00389	CbGpPWpGaD
Terlipressin—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00105	0.00144	CcSEcCtD
Terlipressin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00144	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00105	0.00388	CbGpPWpGaD
Terlipressin—Headache—Etoposide—peripheral nervous system neoplasm	0.00104	0.00142	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00103	0.00382	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.00102	0.00375	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.00101	0.00375	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00101	0.00374	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00101	0.00372	CbGpPWpGaD
Terlipressin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000983	0.00135	CcSEcCtD
Terlipressin—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000982	0.00135	CcSEcCtD
Terlipressin—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000968	0.00133	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000961	0.00132	CcSEcCtD
Terlipressin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.00091	0.00125	CcSEcCtD
Terlipressin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000908	0.00125	CcSEcCtD
Terlipressin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000906	0.00124	CcSEcCtD
Terlipressin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000901	0.00124	CcSEcCtD
Terlipressin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000896	0.00123	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00089	0.00122	CcSEcCtD
Terlipressin—AVPR1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000886	0.00327	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000879	0.00325	CbGpPWpGaD
Terlipressin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000842	0.00115	CcSEcCtD
Terlipressin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000838	0.00115	CcSEcCtD
Terlipressin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000834	0.00114	CcSEcCtD
Terlipressin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000827	0.00113	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000804	0.00297	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000801	0.0011	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000801	0.00296	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000801	0.00296	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000798	0.00295	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000795	0.00294	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000774	0.00286	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000769	0.00284	CbGpPWpGaD
Terlipressin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000766	0.00105	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000743	0.00274	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000741	0.00102	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000739	0.00273	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000734	0.00271	CbGpPWpGaD
Terlipressin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000734	0.00101	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000705	0.0026	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000703	0.0026	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000698	0.00258	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000685	0.00253	CbGpPWpGaD
Terlipressin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000679	0.000931	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000653	0.00241	CbGpPWpGaD
Terlipressin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000635	0.000871	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000599	0.00221	CbGpPWpGaD
Terlipressin—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00059	0.000809	CcSEcCtD
Terlipressin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000588	0.000806	CcSEcCtD
Terlipressin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000581	0.000797	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000555	0.00205	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000551	0.00204	CbGpPWpGaD
Terlipressin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000551	0.000756	CcSEcCtD
Terlipressin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000749	CcSEcCtD
Terlipressin—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000538	0.000738	CcSEcCtD
Terlipressin—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.000699	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000489	0.00181	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000485	0.00179	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000475	0.00175	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000472	0.00174	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000453	0.00167	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000449	0.00166	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000424	0.00157	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000416	0.00154	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000415	0.00153	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000412	0.00152	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000329	0.00122	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.00031	0.00115	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000302	0.00111	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000299	0.0011	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000294	0.00109	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000292	0.00108	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000289	0.00107	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000287	0.00106	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000274	0.00101	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00025	0.000925	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000233	0.000862	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000228	0.000843	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000227	0.000837	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000215	0.000794	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000213	0.000788	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000209	0.000772	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000208	0.000767	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000207	0.000765	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000206	0.00076	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000192	0.000708	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.00019	0.000701	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000188	0.000696	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000183	0.000677	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000174	0.000641	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000172	0.000637	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000162	0.000598	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000162	0.000597	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000161	0.000593	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000133	0.000491	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000132	0.000487	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000127	0.000469	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000126	0.000466	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000112	0.000414	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000111	0.000411	CbGpPWpGaD
